Several local gene therapies have been developed using modified herpes simplex virus 1 (HSV-1) vector carrying wild-type genes, such as COL7A1 for recessive dystrophic epidermolysis bullosa or TGM1 for autosomal recessive congenital ichthyosis [15]. Here, TGM1 is linked to recessive dystrophic epidermolysis bullosa.